Biotech · Private company · Seattle, WA, US
InBios International, Inc.
Track this companyFree. Adds InBios International, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- Active Anthrax Detect™ Plus (AAD Plus)AnthraxClinicalTrials.gov · fetched Nov 12, 2026
- COVID/Flu Detect™ Rapid Self-TestCOVID-19ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Prospective Clinical Evaluation of COVID/Flu Detect™ Rapid Self-Test in Symptomatic Subjects for Non-Prescription Over-the-Counter (OTC) UseCOMPLETED · started Dec 26, 2024ClinicalTrials.gov NCT06734741 · fetched Nov 12, 2026
- Evaluation of the Clinical Specificity of the Active Anthrax Detect™ Plus (AAD Plus) Lateral Flow Immunoassay (LFI)COMPLETED · started Mar 25, 2020ClinicalTrials.gov NCT04320485 · fetched Nov 12, 2026
NIH awards5
- Development of a sensitive Point-of-Care immunoassay for tick- borne spotted fever group rickettsiosesFiscal year 2026 · $314.4KNIH RePORTER 1R41AI197509-01 · fetched Nov 12, 2026
- Development of Next-gen Chagas DetectTM Plus Rapid test for sensitive and specific diagnosis of Chagas diseaseFiscal year 2026 · $974.4KNIH RePORTER 5R44AI184032-03 · fetched Nov 12, 2026
- Development of Next-gen Chagas DetectTM Plus Rapid test for sensitive and specific diagnosis of Chagas diseaseFiscal year 2025 · $989KNIH RePORTER 5R44AI184032-02 · fetched Nov 12, 2026
- Development of Next-gen Chagas DetectTM Plus Rapid test for sensitive and specific diagnosis of Chagas diseaseFiscal year 2024 · $1MNIH RePORTER 1R44AI184032-01 · fetched Nov 12, 2026
- TOPIC 455: DEVELOPMENT OF A RAPID AT-HOME TEST TO DETECT PROSTATE-SPECIFIC ANTIGEN USING SELF-COLLECTED FINGER STICKBLOODFiscal year 2024 · $399.9KNIH RePORTER 75N91024C00078-0-9999-1 · fetched Nov 12, 2026